current market price of YS contracted product is circa US$300t...

First 10 Last

Share
Profile

Follow
Franpower

204 Posts.

413

24/07/24

10:40

Post #: 74888973
Share

Originally posted by halo_3000: ↑

This is my opinion if I was the other party in this JV, it's not fact, but what I have seen before and I believe 2ic has made the right call.

What I have seen in the past:

when an Australian mine is owned mostly overseas and that overseas entity is binded to take off the processed concentrate overseas, the Australian business is at complete mercy to the takeoff, 50% owner because that's where a good chunk of the revenue comes from.

its not in the overseas companies interest for the profits in Australia due to company tax and gst ! All they are after is controlling their own international supply of TiO2 which is something they don't have mines on domestically.

they will likely just pay enough and string out cash payments just enough to keep the lights on until it's no longer profiting offshore or used as market leverage against other suppliers.

sfx is basically at the mercy of their offtake partner / owner. And you can argue all you like they have a fix contract, they will just invoice Australia product quality, shipping, logistical penalties or marketing or whatever to reduce their payments.

they can do whatever they want, it's in there interest for the mine to fail, and take over the other 50% interest

Expand

current market price of YS contracted product is circa US$300t vs contracted price of US$123t

SFX Price at posting: 29.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 50 more messages in this thread...

First 10 Last

Add SFX (ASX) to my watchlist

(20min delay)
Last 29.0¢		Change -0.005(1.69%)		Mkt cap ! $116.4M

Open	High	Low	Value	Volume
30.0¢	30.0¢	29.0¢	$9.733K	32.66K

Buyers (Bids)

No.	Vol.	Price($)
2	3356	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.5¢	68023	1

View Market Depth

No.	Vol.	Price($)
1	20000	0.300
2	11977	0.295
1	689	0.290
1	10650	0.280
1	50000	0.275

Price($)	Vol.	No.
0.305	5312	1
0.310	16129	1
0.320	107149	4
0.330	40000	1
0.340	22022	1

Last trade - 10.11am 04/10/2024 (20 minute delay)

SFX (ASX) Chart

current market price of YS contracted product is circa US$300t...

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

current market price of YS contracted product is circa US$300t...

Top Stories

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News